RNA sequencing data from the Broad Institute’s Cancer Cell Line Encyclopaedia (CCLE) show higher levels of CHAF1A (https://portals.broadinstitute.org/ccle/page?gene=CHAF1A) (accessed on 20 May 2021), CHAF1B (https://portals.broadinstitute.org/ccle/page?gene=CHAF1B) (accessed on 20 May 2021) and RBBP4 (https://portals.broadinstitute.org/ccle/page?gene=RBBP4) (accessed on 20 May 2021) expression in leukaemias and lymphomas in comparison to other tumours. This evidence concerns the gene CHAF1A and lymphoma.